Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ahram Biosystems is a biotechnology company specializing in the development of ultra-fast and portable molecular diagnostic systems. The company's core technology, Palm PCR, enables rapid thermal cycling, significantly reducing the time required for DNA amplification from hours to minutes. Their product portfolio includes portable thermal cyclers and related reagents designed for point-of-care testing, field research, and clinical diagnostics. Headquartered in Seoul with a presence in the United States, Ahram Biosystems aims to decentralize molecular testing through high-performance, battery-powered devices suitable for use outside traditional laboratory settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ahram Biosystems.